
iLivTouch® Clinical research
2025-05-29
Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard (IF=3.5)
To estimate the performance of the FibroTouch-based ultrasound attenuation parameter (UAP) for assessing hepatic steatosis in nonalcoholic fatty liver disease (NAFLD), with magnetic resonance imaging proton density fat fraction (MRI-PDFF) as the reference standard.
2025-05-29
Predictors of high cardiovascular risk among nonobese patients with type 2 diabetes and non-alcoholic fatty liver disease in a Chinese population (IF=3.3)
This study aims to investigate cardiovascular risk factors in nonobese patients with type 2 diabetes (T2DM)
and nonalcoholic fatty liver disease (NAFLD) and to determine whether they might be used to predict high-risk
individuals effectively.
and nonalcoholic fatty liver disease (NAFLD) and to determine whether they might be used to predict high-risk
individuals effectively.
2025-05-19
Frequency of MASLD in Inflammatory Bowel Disease
The aim of our study is to describe the frequency of non-alcoholic hepatic fibrosis and steatosis, as well as MASLD in patients with inflammatory bowel disease and to describe theassociated factors for these conditions.
2025-05-19
Implementation of aerobic exercise intervention in patients with metabolic associated fatty liver disease: A prospective study
To evaluate the intervention effect of moderate intensity aerobic exercise on patients with metabolic-associated fatty liver disease (MAFLD), and to preliminarily explore the intervention program, so as to provide theoretical basis and new ideas for the effective prevention and treatment of MAFLD.
2025-05-19
The value of FibroTouch fat attenuation parameter in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
To explore the diagnostic value of FibroTouch fat attenuation parameter in CHB patients complicated with NAFLD.
2025-05-19
Clinical significance of FibroTouch, ultrasound, and computed tomography in diagnosis of fatty liver disease: a comparative analysis
To investigate the clinical significance of image-guided transient elastography FibroTouch with fat attenuation parameter (FAP) in the diagnosis of fatty liver disease.
2025-05-19
Performance of transient elastography in diagnosis of nonalcoholic fatty liver disease
To investigate the value of transient elastography (TE) in the diagnosis of NAFLD.
2025-05-19
Diagnosis value of MRI IDEAL-IQ and FibroTouch for the hepatic steatosis (IF=6.6)
To discuss the diagnostic value of FibroTouch for hepatic steatosis with magnetic resonance IDEAL-IQ sequence as the criterion.